Parcion Private Wealth LLC Buys Shares of 2,467 Agilent Technologies, Inc. $A

Parcion Private Wealth LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,467 shares of the medical research company’s stock, valued at approximately $291,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Verdence Capital Advisors LLC boosted its holdings in Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after purchasing an additional 86 shares during the last quarter. Valeo Financial Advisors LLC boosted its holdings in Agilent Technologies by 3.0% in the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares during the last quarter. Cary Street Partners Financial LLC boosted its holdings in Agilent Technologies by 2.9% in the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares during the last quarter. Bartlett & CO. Wealth Management LLC boosted its holdings in Agilent Technologies by 5.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock valued at $281,000 after purchasing an additional 116 shares during the last quarter. Finally, Stratos Wealth Partners LTD. boosted its holdings in Agilent Technologies by 0.3% in the 1st quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock valued at $4,835,000 after purchasing an additional 124 shares during the last quarter.

Analyst Ratings Changes

Several research firms have weighed in on A. TD Cowen boosted their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective on the stock. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Evercore ISI upped their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Price Performance

Shares of A opened at $146.01 on Thursday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The firm’s 50 day moving average price is $129.24 and its 200 day moving average price is $118.56. The company has a market cap of $41.39 billion, a P/E ratio of 34.27, a PEG ratio of 4.76 and a beta of 1.26. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the firm earned $1.32 EPS. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is presently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.